跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack
Approved
STANDARD
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
1f5fdf8b8d0eef92
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
1f5fdf8b8d0eef92
Product Name
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack
Artg Id
201320
Artg Name
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
2013-11-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/12781402460cb7c3419c52f1101f33fe.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2f144ab8827951283b46ba35427dcdcd.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
1f5fdf8b8d0eef92
Type
Standard
Back to TGA Approvals
GIOTRIF afatinib 50 mg (as dimaleate) film coated tablet blister pack - TGA Drug Approval Details
